TELETRADER News
11/25/2021, 2:49 PM (Source: TeleTrader)
more TeleTrader news

RDIF: Sputnik most efficient jab in study in Hungary

The Russian Direct Investment Fund (RDIF) claimed in a statement on Thursday that its Sputnik V coronavirus vaccine was the most efficient jab in an independent study conducted in Hungary.

The trial compared five vaccines, and also included jabs developed by AstraZeneca plc, Moderna Inc., Pfizer/BioNTech, and Sinopharm. According to RDIF's statement, the Russian shot has shown 98% efficacy in preventing hospitalization and death, while Moderna and Sputnik were the two best jabs in regard to their ability to prevent infections.

Earlier this week, Moscow approved the use of Sputnik V for children aged between 12 and 17.

Baha Breaking News (BBN) / BU